Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

PARP inhibitors and the rising incidence of secondary myelodysplastic syndrome and acute myeloid leukemia: A comprehensive meta-analysis

Shehab Mohamed, Abdulrahman Al-Mashdali, Anas Babiker, Noor Moustafa, Wafa Mohammed, Mohamad Dulli, Dina Soliman, Deena Mudawi, Sara Aldali, Rowan Mesilhy, Honar Charif

Blood (2025) 146 (Supplement 1): 7390.

https://doi.org/10.1182/blood-2025-7390

Published: 2025

Journal Articles

Outcomes of plasmapheresis in patients with HLH: A nationwide analysis from 2016–2022

Adnan Humam Hajjar, Abdulmalek Aljafari, Shehab Mohamed, Khaled Elhusseiny, Abdulrahman Al Kotob, Parnita Kesar

Blood (2025) 146 (Supplement 1): 2992.

https://doi.org/10.1182/blood-2025-2992

Published: 2025

Journal Articles

Tailored prophylaxis in severe hemophilia A: Real-world experience with efanesoctocog alfa

Amna Gameil, Rawan Dawoud, Aliaa Amer, Fareeda Alam, Shehab Mohamed, Hajer Al-Mulla, Fatima Taloozy, Deena Mudawi, Anas Hamad, Honar Charif, Liam Joseph

Blood (2025) 146 (Supplement 1): 6626.

https://doi.org/10.1182/blood-2025-6626

Published: 2025

Journal Articles

Characterizing thrombosis in acute promyelocytic leukemia: Real-world insights from the middle east

Hawraa Shawaylia, Rafal Alshebly, Anil Yousaf, Rola Ghasoub, Dina Soliman, Deena Mudawi, Abdulrahman Al-Mashdali, Mohammed Termanini, Hesham Elsabah, Anas Hamad, Honar Charif, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 6612.

https://doi.org/10.1182/blood-2025-6612

Published: 2025

Journal Articles

Impact of essential thrombocythemia on in-hospital outcomes and thrombotic complications in patients hospitalized with COVID-19: A national inpatient sample analysis (2016–2022)

Adnan Humam Hajjar, Abdulmalek Aljafari, Abdulmoiz Aljafari, Shehab Mohamed, Ahmed Hebishy

Blood (2025) 146 (Supplement 1): 5604.

https://doi.org/10.1182/blood-2025-5604

Published: 2025

Journal Articles

From crisis to cure? thirteen years of real-world trends in acute promyelocytic leukemia outcomes in Qatar

Ghasoub Rola, Hesham Elsabah, Anas Hamad, Nabeel Qasem, Hawraa Shawaylia, Feryal Hilmi, Halima El Omri, Rajvir Singh, Shehab Mohamed, Abdulrahman Al-Mashdali, Anil Yousaf, Honar Cherif

Blood (2025) 146 (Supplement 1): 6926.

https://doi.org/10.1182/blood-2025-6926

Published: 2025

Journal Articles

Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif

Blood (2025) 146 (Supplement 1): 6662.

https://doi.org/10.1182/blood-2025-6662

Published: 2025

Journal Articles

Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence

Abdulrahman Al-Mashdali, Samah M Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 1326.

https://doi.org/10.1182/blood-2025-1326

Published: 2025

Journal Articles

Prevalence and risk of aortic aneurysms in JAK2-positive myeloproliferative neoplasms: A multi-study review

Mohamad Dulli, Abdulrahman Al-Mashdali, Afra Ahmed, Ashraf Ahmed, Mohammad Afana, Mohammad Altermanini, Nabeel Qasem, Noor Moustafa, Samah Kohla, Hawraa Shawaylia, Dina Soliman, Mohammed Yasin, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 7349.

https://doi.org/10.1182/blood-2025-7349

Published: 2025

Journal Articles

Efficacy of fixed-duration venetoclax-based regimens as first-line in chronic lymphocytic leukemia: A systematic review and meta-analysis of clinical trials

Abdulrahman Al-Mashdali, Muhammad Ashar Ali, Wajeeha Aiman, Sara Aldali, Rawan mesilhy, Bassam Muthanna, Mohamed Fawzi Mudarres, Elmustafa Abdalla, Mohammed Elmourtada Mohammed, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 7414.

https://doi.org/10.1182/blood-2025-7414

Published: 2025

Journal Articles

Adults with therapy-related acute lymphoblastic leukemia (t-ALL): A systematic review and meta-analysis

Rowan Mesilhy, Razan Hourani, Muhammad Khan, Dina Soliman, Asma Syed, Honar Charif, Yasmin Elsalkawi, Hafsa Khalid, Abdulrahman Al-Mashdali, Deena Mudawi, Suhail A. Doi, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 6850.

https://doi.org/10.1182/blood-2025-6850

Published: 2025

Journal Articles

Efficacy and safety of CAR-t cell therapy in richter transformation: A systematic review

Abdulrahman Al-Mashdali, Bassam Muthanna, Dina Soliman, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 8089.

https://doi.org/10.1182/blood-2025-8089

Published: 2025

Journal Articles

Q- hemegenome: The Qatar national registry for germline predisposition to myeloid and other hematologic malignancies

Amna Gameil, Mariem Sidenna, Huda Farah, Hajer Al-Mulla, Sara Jemmieh, Feryal Hilmi, Samah Kohla, Yeslem Ekeibed, Mariam Al-Nesf, Salma Taha, Amal Aly, Afraa Fadul, Shehab Mohamed, Tawfeq Omran, Salha Bujassoum, Honar Charif, Reem AL Sulaiman

Blood (2025) 146 (Supplement 1): 7951.

https://doi.org/10.1182/blood-2025-7951

Published: 2025

Journal Articles

Impact of c-KIT and FLT3 mutations on survival outcomes in core-binding factor acute myeloid leukemia: A systematic review and meta-analysis

Hana Qasim, Ben Ponvilawan, Sara Aldali, Mohamed Fawzi Mudarres, Ibrahim Khamees, Abdulrahman Al-Abdulmalek, Ahmed Saleh, Wajeeha Aiman, Muhammad Ashar Ali, Abdulrahman Al-Mashdali, Rawan mesilhy, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 7006.

https://doi.org/10.1182/blood-2025-7006

Published: 2025

Journal Articles

Chronic Myelomonocytic Leukemia 10 Years of Single Institute Experience

Samah Ahmed Samy Kohla, Abdulrahman Al-Mashdali, Hawra Shawayli, Sarah Elkourashy, Dina Sameh Soliman, Kalpana Singh, Susanna Akiki, Mohammed Yasin, Feryal Abbas, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 6703.

https://doi.org/10.1182/blood-2024-202469

Published: 2024

Journal Articles

Brentuximab Vedotin Is Effective in Sever and Diffuse Lymphomatoid Papulosis, Case Reports

Hawra Shawayli, Yeslem Mohamed Ekeibed, Shehab Mohamed, Sarah Elkourashy, Afaf Albattah, Dina Sameh Soliman, Ruba Yasin Taha

Blood (2024) 144 (Supplement 1): 6416.

https://doi.org/10.1182/blood-2024-209956

Published: 2024

Journal Articles

Review of Rare Association between Chronic Lymphocytic Leukemia and Chromic Myeloid Leukemia

Elmustafa Abdalla, Abdalla Fadul, Ahmed Elmudathir Osman, Gihan Mohamed, Dina Sameh Soliman, Hawra Shawayli, Tareq Abuasab, Motaz Almahmood, Amin Saied, Mohamed Mohamed, Shahd Ahmed, Kalpana Singh, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 6805.

https://doi.org/10.1182/blood-2024-205929

Published: 2024

Journal Articles

AL Amyloidosis with Nephrotic Syndrome: Clinical Response to Treatment Only after a Long-Term Maintenance Therapy with Daratumumab

Hawra Shawayli, Honar Cherif, Dina Sameh Soliman, Deena Mudawi, Elmustafa Abdalla, Abdulrahman Al-Mashdali, Mohammed Abdulgayoom, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 6873.

https://doi.org/10.1182/blood-2024-201993

Published: 2024

Journal Articles

Maternal and Neonatal Outcomes in Pregnant Patients with Immune Thrombocytopenia: A Retrospective Study

Sarah Elkourashy, Hassan Magboul, Dina Sameh Soliman, Mohammed Al Najjar, Elmustafa Abdalla, Hawra Shawayli, Manar Elsheikh, Nayela Al mallahi, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 5460.

https://doi.org/10.1182/blood-2024-201976

Published: 2024

Journal Articles

Serious Bleeding Manifestations in Patients with Newly Diagnosed Acute Myeloid Leukemia: A Single Center Experience

Mohammed Abdulgayoom, Hawra Shawayli, Dina Sameh Soliman, Elmustafa Abdalla, Deena Mudawi, Feryal Abbas, Susanna Akiki, Yousef Al-Asa'd, Ahmed Ali, Kalpana Singh, Honar Cherif, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 5976.

https://doi.org/10.1182/blood-2024-205585

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

PARP inhibitors and the rising incidence of secondary myelodysplastic syndrome and acute myeloid leukemia: A comprehensive meta-analysis

Outcomes of plasmapheresis in patients with HLH: A nationwide analysis from 2016–2022

Tailored prophylaxis in severe hemophilia A: Real-world experience with efanesoctocog alfa

Characterizing thrombosis in acute promyelocytic leukemia: Real-world insights from the middle east

Impact of essential thrombocythemia on in-hospital outcomes and thrombotic complications in patients hospitalized with COVID-19: A national inpatient sample analysis (2016–2022)

From crisis to cure? thirteen years of real-world trends in acute promyelocytic leukemia outcomes in Qatar

Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence

Prevalence and risk of aortic aneurysms in JAK2-positive myeloproliferative neoplasms: A multi-study review

Efficacy of fixed-duration venetoclax-based regimens as first-line in chronic lymphocytic leukemia: A systematic review and meta-analysis of clinical trials

Adults with therapy-related acute lymphoblastic leukemia (t-ALL): A systematic review and meta-analysis

Efficacy and safety of CAR-t cell therapy in richter transformation: A systematic review

Q- hemegenome: The Qatar national registry for germline predisposition to myeloid and other hematologic malignancies

Impact of c-KIT and FLT3 mutations on survival outcomes in core-binding factor acute myeloid leukemia: A systematic review and meta-analysis

Chronic Myelomonocytic Leukemia 10 Years of Single Institute Experience

Brentuximab Vedotin Is Effective in Sever and Diffuse Lymphomatoid Papulosis, Case Reports

Review of Rare Association between Chronic Lymphocytic Leukemia and Chromic Myeloid Leukemia

AL Amyloidosis with Nephrotic Syndrome: Clinical Response to Treatment Only after a Long-Term Maintenance Therapy with Daratumumab

Maternal and Neonatal Outcomes in Pregnant Patients with Immune Thrombocytopenia: A Retrospective Study

Serious Bleeding Manifestations in Patients with Newly Diagnosed Acute Myeloid Leukemia: A Single Center Experience

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only